WEIKANG BIO-TECHNOLOGY GROUP CO., INC. Operating Income
WEIKANG BIO-TECHNOLOGY GROUP CO., INC. reported Operating Income of $4.60 million for the 3-month period ending 2012-09-30, per its 10-Q/A filed 2012-12-11.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2012-12-11
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. operating income (loss) for the quarter ending 2012-09-30 was $4.60M, a 33.49% increase year-over-year.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. operating income (loss) for the quarter ending 2012-06-30 was $2.07M, a 62.84% decline year-over-year.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. operating income (loss) for the quarter ending 2012-03-31 was $8.68M, a 42.76% decline year-over-year.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. operating income (loss) for the quarter ending 2011-12-31 was $18.13M, a 11.05% increase year-over-year.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. operating income (loss) for fiscal 2011 was $42.30M, a 25.59% increase from fiscal 2010.
- WEIKANG BIO-TECHNOLOGY GROUP CO., INC. operating income (loss) for fiscal 2010 was $33.68M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2012-09-30 | $4.60M 10-Q/A · filed 2012-12-11 | $6.67M derived: sum of 2 quarters · filed 2012-12-11 | $15.35M 10-Q/A · filed 2012-12-11 | $33.48M derived: sum of 4 quarters · filed 2012-12-11 |
| 2012-06-30 | $2.07M 10-Q/A · filed 2012-08-30 | $10.74M 10-Q/A · filed 2012-08-30 | $28.87M derived: sum of 3 quarters · filed 2012-08-30 | $32.32M derived: sum of 4 quarters · filed 2012-12-11 |
| 2012-03-31 | $8.68M 10-Q · filed 2012-05-15 | $26.81M derived: sum of 2 quarters · filed 2012-05-15 | $30.26M derived: sum of 3 quarters · filed 2012-12-11 | $35.81M derived: sum of 4 quarters · filed 2012-12-11 |
| 2011-12-31 | $18.13M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-30 | $21.58M derived: sum of 2 quarters · filed 2012-12-11 | $27.14M derived: sum of 3 quarters · filed 2012-12-11 | $42.30M 10-K · filed 2012-03-30 |
| 2011-09-30 | $3.45M 10-Q/A · filed 2012-12-11 | $9.01M derived: sum of 2 quarters · filed 2012-12-11 | $24.17M 10-Q/A · filed 2012-12-11 | $40.49M derived: sum of 4 quarters · filed 2012-12-11 |
| 2011-06-30 | $5.56M 10-Q/A · filed 2012-08-30 | $20.72M 10-Q/A · filed 2012-08-30 | $37.04M derived: sum of 3 quarters · filed 2012-08-30 | $45.17M derived: sum of 4 quarters · filed 2012-08-30 |
| 2011-03-31 | $15.16M 10-Q · filed 2012-05-15 | $31.49M derived: sum of 2 quarters · filed 2012-05-15 | $39.61M derived: sum of 3 quarters · filed 2012-05-15 | $42.47M derived: sum of 4 quarters · filed 2012-05-15 |
| 2010-12-31 | $16.33M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $24.45M derived: sum of 2 quarters · filed 2012-03-30 | $27.31M derived: sum of 3 quarters · filed 2012-03-30 | $33.68M 10-K · filed 2012-03-30 |
| 2010-09-30 | $8.13M 10-Q · filed 2011-11-21 | $10.98M derived: sum of 2 quarters · filed 2011-11-21 | $17.35M 10-Q · filed 2011-11-21 | |
| 2010-06-30 | $2.86M 10-Q/A · filed 2011-09-01 | $9.22M 10-Q/A · filed 2011-09-01 |